// App-Quantinova.ai

: Hydroxyurea Therapy Does Not Impact Current Survival Estimates in the East London Sickle Cell Newborn Cohort Study

Researchers

Presenter

  • Paul Telfer

Principal Investigators

  • Banu Kaya

  • Dimitris A. Tsitsikas

  • Filipa Barroso

  • Cynthia Sangarappillai

Medical Centers

  • Barts Health NHS Trust, London, United Kingdom

  • Barts Health NHS Trust, London, UK

  • Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved